March 5, 2020 / 9:28 AM / a month ago

BRIEF-Grindeks Announces Successful Completion Of Phase 1 Clinical Study

March 5 (Reuters) - Grindeks AS:

* ANNOUNCES THAT IT HAS COMPLETED THE PHASE 1 CLINICAL STUDY OF ITS NEW INVESTIGATIONAL MEDICINAL PRODUCT METYL-GBB

* PRECLINICAL AND CLINICAL PHASE 1 STUDIES SHOW A VERY GOOD SAFETY PROFILE OF THE INVESTIGATIONAL MEDICINAL PRODUCT

* PLANS TO INITIATE PHASE II CLINICAL STUDIES AND IS CURRENTLY SEEKING A STRATEGIC PARTNER WITHIN THE PHARMACEUTICAL INDUSTRY Source text : Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below